Cancer therapy with a parvovirus combined with bevacizumab
US-2021060102-A1 · Mar 4, 2021 · US
This page is not indexed by search engines while we improve data quality.
Ruprecht Karls Univ patents
Ruprecht Karls Univ holds 4 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 4 |
| Recent patents | 0 |
| First publication | Dec 25, 2018 |
| Latest publication | Mar 4, 2021 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Rna viruses expressing il-12 for immunovirotherapy
US-2019315825-A1 · Oct 17, 2019 · US
RNA viruses expressing IL-12 for immunovirotherapy
US-10344067-B2 · Jul 9, 2019 · US
Means and methods for treating or diagnosing IDH1 R132H mutant-positive cancers
US-10161940-B2 · Dec 25, 2018 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Cancer therapy with a parvovirus combined with bevacizumab
US-2021060102-A1 · Mar 4, 2021 · US
Rna viruses expressing il-12 for immunovirotherapy
US-2019315825-A1 · Oct 17, 2019 · US
RNA viruses expressing IL-12 for immunovirotherapy
US-10344067-B2 · Jul 9, 2019 · US
Means and methods for treating or diagnosing IDH1 R132H mutant-positive cancers
US-10161940-B2 · Dec 25, 2018 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 4 |
| Chemistry & Metallurgy | 4 |
| Physics | 1 |